| Logo | Name | Σ | Employees |
|---|---|---|---|
|
Leading biotechnology company who supports scientists worldwide with high-end human cell culture products and services. At PromoCell, we help scientists do better research with a world-class portfolio of human primary, stem and blood cells as well as optimized cell culture media. With over 35 years of expertise, we are recognized globally for supplying scientists with the tools and support they need to do groundbreaking research. All our products comply with European biomedical conventions, ensuring human rights and donor privacy are always protected. Our ISO certifications demonstrate our absolute commitment to quality and our EXCiPACTTM GMP certification enables us to produce … 139 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology |
5 | 95 |
|
Drugging the Undruggable® PhoreMost is a new-model drug discovery company based in Cambridge, UK. We are dedicated to ‘Drugging the Undruggable®’ disease targets using our next-generation technology, SITESEEKER®. Using PROTEINi® libraries, this unique drug target identification platform can discern the best new targets for future therapy and crucially, how to drug them, which has the potential to significantly increase the diversity and affordability of novel therapeutics for cancer and other unmet diseases. PhoreMost is building a pipeline of novel drug discovery programmes aimed at addressing a range of diseases, with a mission to accelerate, diversify and rationalise drug discovery. Using … 241 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
6 | 31 |
|
Reimagining known biology to deliver high impact medicines Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline includes three clinical-stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-β agonist and preclinical GIPR modulator programs. For more information, please visit: www.ternspharma.com. Pharmaceuticals, Liver Disease, Life Sciences, BioPharmaceuticals, CML, Oncology, and HemOnc 342 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
1 | 61 |
|
Decoding Metabolic Health with Explainable AI At MedInsights, we are dedicated to bringing optimized therapeutic options for patients suffering from metabolic, cardiometabolic, neurometabolic and rare diseases with high unmet needs. Our internal drug repositioning engine, NexusRx, serves as a cornerstone for our discovery research, employing internal sets of proprietary algorithms to detect unknown and unforeseen relationships between disease-targets-drugs. This opens up preclinical validation opportunities which we perform in close partnerships with our academic collaborators. We envision to perform clinical trials and bring therapeutics from lab to bed side. Crunchbase profile: https://www.crunchbase.com/organization/medinsights-0569 Biotech, Data Science, Healthcare, Computer Vision, Generative AI, Network … 533 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. A.I. - Machine Learning Data Analytics |
42 | 7 |
|
BioNB now ResearchNB
BioNB is now ResearchNB Driving New Brunswick’s bioeconomy: BioNB connects, supports, and advocates for NB’s biosciences sector. BioNB offers a range of business services from proposal editing to collateral design and business plan development to pitch coaching. BioNB hosts regular events to foster sector networking and educate companies, decision makers and the public on current issues and emerging trends. In collaboration with a vibrant ecosystem of companies, research institutions and partners, BioNB is dedicated to enabling a thriving bioeconomy in our region. Business development, Pre-commercial activities, Funding program navigation, Technology translation, Event planning, Proposal support, Bioeconomy, and Commercialization 36 similar entities Type: SMB Activities: biotech deeptech |
7 | 1 |
|
Neocor is dedicated to pioneering transformative therapies in cardiac care We are currently developing a novel gene therapy approach targeting ischemic and rare genetic cardiac diseases, and moving from lab preclinical trials to regulatory trials. The Company was founded in October and has received strong traction since inception. We will be looking to strengthen our human and financial ressources in the coming month in order to start the regulatory pre clinical trials. gene therapy, biotechnology, rare disease, and cardiology 343 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
6 | 5 |
|
Join us to discover the latest life science research, news, expert insights, and light-hearted content. The Scientist, the magazine of the life sciences, and the 2008 and 2009 ASBPE Magazine of the Year, has informed global life science professionals for over 25 years. We provide our print and online magazine readers with coverage of the latest developments in the life sciences including trends in research, new technology, news, business and careers. We reach the leading researchers and executive management in academia and industry who are interested in maintaining a broad view of the life sciences by reading insightful content that … 52 similar entities Type: SMB Activities: deeptech biotech martech |
2 | 43 |
|
The Cell Therapy Venture Builder MedXCell is a European cell therapy venture builder with a strong industrial mindset and a global perspective. Our focus is on technologies, techniques or novel applications in major diseases such as cancer, autoimmune, neurological and degenerative disorders. Established in 2018, we have offices in Switzerland, the EU (France) and the US (Cambridge, MA) and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development and funding capabilities. Biotechnology, Cell Therapy, Immunotherapy, NK Cells, Mesenchymal Stromal Cells, Immuno-oncology, and Osteoarthritis 583 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology |
1 | 8 |
|
Business developer for life sciences in the Stuttgart & Neckar-Alb BioRegio STERN Management GmbH has been working as an economic developer for the life sciences since 2001. It promotes innovations, start-ups and small and medium-sized companies on a public mission. It is a central contact point for founders and entrepreneurs from the areas of biotechnology and medical technology and also from cooperating high-tech sectors such as automation and IT. The STERN BioRegion with the Stuttgart and Neckar-Alb regions and the cities of Tübingen and Reutlingen is home to over 120 medium-sized medical technology companies. The combination of established family businesses, … 39 similar entities Type: SMB Activities: deeptech |
19 | 16 |
|
We do the research, so that no more lives are cut short from breast cancer | #nomorelivescutshort Breast Cancer Trials is a group of world-leading breast cancer doctors and researchers based in Australia and New Zealand with a commitment to exploring and finding better treatments for people affected by breast cancer through clinical trials research. Formerly known as the Australia & New Zealand Breast Cancer Trials Group and our fundraising department, the Breast Cancer Institute of Australia, we are on a mission for people affected by breast cancer to live better, to live longer and to never die from breast … 45 similar entities Type: SMB Activities: biotech deeptech |
10 | 78 |
|
Novalix is a premier drug discovery CRO Novalix is a premier drug discovery partner to biotech firms and pharmaceutical companies. We apply our exceptional scientific talent and exclusive resources across our platforms to improve the odds of success at each critical pre-clinical stage. The better the science, the better the outcomes. For additional information visit www.novalix.com Target based drug discovery, NMR, SPR, Epigenetic targets, Nuclear receptors, Protein-ligand co-crystal structures by XRD, Native mass spectrometry, FBDD, Organic Chemistry, cryo-electron microscopy, Chemical development, Medicinal chemistry, Structural Biology, in vitro pharmacology, DNA-encoded libraries, Flow chemistry, Chemical process research, DMPK, and ADME 526 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology |
44 | 325 |
|
Science to Transform Lives Immunocore is a leading T cell receptor (TCR) biotechnology company working to create first-in-class biological therapies to address unmet patient needs in oncology as well as infectious and autoimmune diseases. See our community guidelines: http://bit.ly/2kFA8hr Biotechnology, Cancer, Oncology, Infectious Diseases, Autoimmune Diseases, T Cell Receptor, Immunotherapy, ImmTAX, ImmTAC, ImmTAV, and ImmTAAI 273 similar entities Type: Startup Activities: deeptech hrtech biotech Technologies: Synthetic Biology |
11 | 607 |
|
Helping health & biotech companies, researchers and entrepreneurs making their projects and dreams come true. GENESIS Biomed is a consultancy firm in the biomedical healthcare sector specialized in providing consulting services in the genesis and first phases of lifecycle of biomedical spin-off and start-up companies, entrepreneurs and research centers. Based in our expertise we help entrepreneurs and researchers to shape their business plan and we support them in the private fundraising process. We have raised 68,5 M€ in the last years in 20 rounds. We are Associate Partner at EIT Health and we are engaged to 23 EU projects with … 252 similar entities Type: SMB Activities: deeptech healthtech consulting entrepreneurship fintech biotech Technologies: A.I. |
12 | 14 |
|
Transforming Labs with AI and Automation Reshape Biotech is building the next generation of lab automation robots. Our customers are biotech companies tackling the world’s biggest problems - be it alternative protein development or sustainable agriculture. Reshape Biotech is the scaling factor for these companies, as we let researchers collaborate globally on experiments and increase their throughput >500x. The team is highly multi-disciplinary, employing everything from PhD’s in biology to hardware and software engineers. We work closely together, and you will be exposed to a truly vertical team. We’re a fast growing startup with an incredibly ambitious team, dead-set on … 130 similar entities Type: Startup Activities: deeptech biotech Technologies: Robotics |
3 | 63 |
|
Innovate Undertake Valorize For more than 15 years JBiotech Conseil has supported projects with high innovation potential in the field of human health and biotechnologies. Complete expertise We master the strategic, scientific, technical, operational, HR, communication and investor relations components necessary to succeed in a health innovation project. Personalized support We offer specific and tailor-made support, from start-ups to the first stages of growth, including the professional and personal development of managers and teams. A network of experts We have built a solid network of partner experts over 15 years, covering the essential disciplines for the success of your startups. … 281 similar entities Type: SMB Activities: healthtech hrtech Technologies: Synthetic Biology |
2 | 2 |
|
CONNECT COLLABORATE EVOLVE Biotrains is a global leader in providing business conferences, training, managed events, and consulting services tailored to the Pharmaceutical, Biotech, Healthcare, and Medical Device industries. We specialize in delivering world-class content and expert knowledge to empower professionals and give organizations a competitive edge. Our events cover technical areas such as Bioprocess Development, Drug Discovery, Diagnostics, Personalized Medicine, Medical Devices, and Healthcare. With a focus on innovation and continuous learning, Biotrains is dedicated to fostering success in both business and academia. Event , Conference, Trainnig, Pharmaceutical, Biotechnology, Home Healthcare, Pharma IT, drugformulation, and workshops 110 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
7 | 33 |
|
The Euro/Global Platform for Drug Repurposing REPO4EU is the Euro/Global Platform for Drug Repurposing - from imprecise drug therapy to AI-powered precision medicine. Should you need any help in searching for bioinformatics support for an unmet medical need, a registered compound or a specific mechanism; exploring your freedom to operate or a patenting strategy or regulatory advice; liaising with a business partner, setting up a clinical trial test site for phase I-III or crafting a business plan... we have the experts and global experience to help and work with you! bioinformatics, drug repurposing, artificial intelligence, and pharmacology 217 similar entities Type: Startup Activities: biotech Technologies: SaaS |
2 | 26 |
|
Shaping the future of Life Sciences EXECUTIVE SEARCH LEADERSHIP ADVISORY SPECIALIZED IN LIFE SCIENCES At Hahn Zekker, we support Life Sciences companies (MedTech, Pharma, Biotech) to attract, assess, and develop transformational leaders globally. With 20+ years’ international experience, we partner with ambitious organizations to drive growth, innovation, and impact through people. Let’s shape the future of Life Sciences, together. Life Sciences, Pharma, Medtech, Biotech, Medical Devices, Start-Up, Executive Search, Coaching, Mentoring, Training, Assessment, HR, Consultancy, and Advise |
2 | 6 |
|
Wellfundr, the first crowdfunding platform dedicated to health, accelerates projects that will allow us to live better tomorrow. Alongside researchers, entrepreneurs, associations and communities, Wellfundr helps bring their projects to life and supports their development. Wellfundr facilitates access to financial and human resources. Crowdfunding, Health, eHealth, Innovation, Association, Medical, and Student 42 similar entities Type: Startup Activities: healthtech Technologies: SaaS |
10 | N/A |
|
Smart Treatment of Diabetes and other Chronic Diseases. Join the needle-free Revolution! MedicSen is a startup founded by young Spaniards with the aim of launching a treatment that will forever change the way we deal with diabetes. They have created an application capable of integrating information from continuous glucose meters with other parameters, entered by the user or collected by smart devices, to offer a record of their glycemic values and give a reliable prediction of future values, thanks to an innovative learning algorithm that communicates with the user through a chat-bot type interface. This provision will provide greater peace … 294 similar entities Tags: H2020 Type: Startup Activities: healthtech deeptech Technologies: Sensors |
13 | 21 |
|
Bringing People & Ressources Together The creation of Genbiotech, a spinoff of the Laboratoires Genévrier results of 15 years of strategic involvement in biotechnological research with one goal: to improve the quality of life of patients in the field of rheumatology, dermatology and aesthetic. We believe that tomorrow medicine needs to be dedicated and targeted to patients. We aim to improve existing treatments by using non invasive processes allowing local and sustained administration of biological and active molécules. The company, incepted in 1998, has currently a staff of 11 people and is located in Sophia Antipolis (South of France). For … 643 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
1 | 8 |
|
Your Partner in Cell Research / From Cell Research to Cell Analysis YOUR Partner in Cell Research - At OLS OMNI Life Science, we empower researchers and innovators in life sciences and biotechnology with smart, reliable, and user-friendly technologies that accelerate cell research and discovery. Driven by a commitment to people and partnership, we collaborate closely with scientists, organizations and our manufacturers to deliver solutions that make a real impact — from research to bioproduction. Our portfolio includes advanced tools and systems designed to enhance cell culture, flow cytometry, analysis, and imaging, enabling our partners to achieve meaningful results faster … 64 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology |
0 | 27 |
|
We are developing the future of drug discovery with a platform to discover, develop, and deliver drug candidates for challenging targets. Sign up for our quarterly newsletter to keep up with our progress: https://lnkd.in/eCH3d6ay 151 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
5 | 45 |
|
Eurofins Discovery offers you a complete, single-source solution for drug discovery products and services. Eurofins Discovery has supported Drug Discovery research for >40 years. Our partners inspire us to innovate in the pursuit of life-changing cures. We provide our experience, depth, and breadth in the form of innovative testing services and product tools that support researchers as they accelerate the discovery and development of candidate molecules. Our global team of dedicated scientists, information analysts, and client support professionals make this mission possible. Our focus drives us to continually expand our portfolio of testing methods, tools, and services to enable real, … 381 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
2 | 212 |
|
goes FAR BEYOND (Fighting Antimicrobial Resistance to the Biological EmergencY to Opportunistic and Neglected Diseases) Dimicare Biotech is a project from Université Côte d'Azur, INSERM and CNRS focused on the development of novel "precision" antimicrobial drugs to fight multidrug-resistant infections. Our main project focuses on the development of a new treatment against multidrug-resistant S. aureus strains (including the WHO priority MRSA; methicillin-resistance S. aureus strains). Currently, this treatment is in the early-preclinical phase where its efficacity against several clinical strains and its innocuity in Human cells has been confirmed. Dimicare Biotech is building a great team involving Microbiology Medical doctors, … 171 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
18 | 1 |
|
Launching the Next Great Genomic Startups Murrieta Genomics is dedicated to advancing the use of genomic sequencing in precision medicine, agriculture, forensics, veterinary and direct to consumer applications by offering entrepreneurs access to the specialized equipment, know-how and mentors that can transform research into commercial enterprise. We are a true incubator, offering dedicated bench space to fledgling companies at basically zero cost, helping them to define their business model and validate their science, and then investing in the companies that “graduate” the incubator. We are located in the 16,000 square foot Murrieta Innovation Center in Southern California, in close proximity … 43 similar entities Type: Startup Activities: biotech deeptech |
1 | 6 |
|
Making Pharma democratic. Nosty is a decentralized platform where stakeholders in drug development work together to bring new therapeutics to patients faster and more efficiently than ever. The platform enables leading researchers and labs to raise fund among patients and the general public by turning IP and its development into a liquid and easily investable asset. The project is led by a team of serial entrepreneurs and professionals from the pharmaceutical industry, based in US and Europe. 55 similar entities Type: Startup Activities: deeptech biotech Technologies: SaaS |
2 | 1 |
|
AI for digital twin of cells DeepLife is an early stage startup founded in 2019 by Jonathan Baptista and Jean-Baptiste Morlot, backed by international investors, developing the first SaaS platform for Digital Twin of cells. While we are able to design and build incredibly complex mechanical engines, engineering biological systems, such as cells, remains a challenge. However, recent technological improvements, notably in biochemistry, recently enabled the construction of databases with millions of quantitative cell activity measures, covering multiple diseases. The DeepLife team develops a SaaS platform combining state-of-the-art deep learning algorithms on multi-omics sequencing data, public and private cell atlases, … 300 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Deep Learning SaaS |
49 | 29 |
|
Our mission at Life Science People is to make a tangible contribution to global health. Talent experts providing scalable, bespoke recruitment solutions for growing Life Science companies. We have experienced teams of recruiters who can advise and hire across all areas within: • Pharmaceutical • Biotechnology • CRO Services • Health Technology • Medical Devices Our services include contingent, retained, and embedded services, our own version of scaled RPO – suited to rapidly growing organisations. We also offer an investment platform, allowing fledgling SME’s access to our large network of qualified investors, VC’s and PE’s. We recruit extensively across APAC, … 92 similar entities Type: Startup Activities: hrtech deeptech healthtech biotech Technologies: SaaS |
0 | 62 |
|
Pioneering Precision Biocontrols Biotalys is an Agricultural Technology (AgTech) company developing precision biocontrol solutions based on proteins for the protection of crops in both the pre- and post-harvest markets. The company provides novel solutions that bridge the efficacy and scale of chemistry with the environmental advantages of biological solutions. Based on its novel AGROBODYTM technology platform, Biotalys is developing a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from … 265 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
11 | 46 |
|
Advancing our proprietary AxiomerTM RNA-editing platform technology Changing lives is what drives us at ProQR Therapeutics. We are advancing our proprietary AxiomerTM RNA-editing platform technology. Our highly energetic team strives to combine innovative technologies and entrepreneurism to make a meaningful impact on the lives of individuals and the people around them. If you are up to this challenge and like to be part of our team, check out our website for vacancies: http://www.proqr.com/careers/ RNA therapeutics, Drug development, Rare Diseases, Genetic Diseases, Orphan drugs, Pharmaceuticals, and RNA editing 173 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
4 | 201 |
|
Pyramid studio embodies an unique way of leading therapeutic innovation to fuel the pipeline of pharmaceutical companies Pyramid Studio is a First-of-its-Kind venture builder dedicated to fuel the pipeline of pharmaceutical companies Pyramid Studio embodies a new way of leading therapeutic innovation through a unique build-to-buy model. Our mission is to bridge the gap for pharmaceutical companies seeking access to breakthrough innovations and delivering new therapies to patients. In practice, our team identifies and rigorously selects groundbreaking innovations from top academic teams across Europe. We collaborate closely with our Pharma partners to co-develop and co-finance these programs, ultimately delivering IND-ready … 296 similar entities Type: Incubators & VCs Startup Activities: deeptech biotech Technologies: Synthetic Biology |
2 | 1 |
|
Health recruitment expert Since 2004, Axeme has supported healthcare players (startups, SMEs, large groups) in their strategic recruitment, in France and internationally. Specialists in medical devices, biotech and digital health, we combine business expertise, responsiveness and human support. We are recruiting profiles in R&D, Quality, Regulatory Affairs, Clinical, Marketing, Business Development, up to management positions (C-Level). Are you recruiting or looking for a new challenge? Let's talk about it. Co-organizer of Experts Medtech: https://expertsmedtech.com/ Headhunter in Medical Device, Biotechnology, Biomedical for Sales, Marketing, Business Development, Management, MedTech Experts, Sales, QARA, Clinical Research, In Vitro Diagnostic, MedTech, Medical device, CEO COO … 125 similar entities Type: SMB Activities: biotech deeptech healthtech martech Technologies: Synthetic Biology |
13 | 13 |
|
Science Creates is a Deep Tech ecosystem that enables scientists and engineers to build disruptive businesses. Science Creates believes that Deep Tech startups are society's most effective economic vehicle to deliver innovation and global impact for the health of people and the health of our planet. We empower, support and inspire people over three decades of their journey in becoming world leading Deep Tech founders. Since 2015, we have supported over 150 startups solving global problems with groundbreaking advancements in healthcare, the environment and quality of life. We have two research facilities in Bristol, an award-winning venture capital arm (SCVC) … 66 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. |
13 | 19 |
|
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. For more information, visit www.bostonscientific.com and connect with us on X, Instagram, and Facebook. At Boston Scientific, you will find purpose, a place to grow … 62 similar entities Type: Large company Startup Activities: healthtech deeptech |
45 | 55,179 |
|
Facilitators of Life Sciences Research We facilitate Life Sciences Research every day, contributing to advance Science for a brighter future. Through our local offices located across Europe, we support Life Sciences and Biotechnology Researchers with a unique, holistic range of solutions to advance their projects faster: - We enable researchers to be at the forefront in their Research with access to cutting-edge biological solutions sourced from reputed global Life Sciences suppliers, carefully selected by our Scientific Team for their relevance and evaluated for their ethical and legal compliance. - We accelerate their Research thanks to our Contract Research Services’ … 130 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology |
16 | 74 |
|
Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases. BioNTech is a global next generation biopharmaceutical company pioneering novel investigative therapies for cancer and other serious diseases. In oncology, BioNTech is committed to transforming how cancer is treated. Its ambition is to develop innovative medicines with pan-tumor or synergistic potential to address cancer from multiple angles and across the full continuum of the disease from early- to late-stage. Its growing late-stage oncology pipeline comprises complementary treatment approaches spanning immunomodulators, antibody drug conjugates, and mRNA cancer immunotherapies. BioNTech has partnered … 269 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
42 | 5,180 |
|
The Cell Coding Company bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. We have developed an end-to-end platform for the creation of any human cell type. With our cutting-edge and patent-protected opti-ox precision cell programming technology, we can deterministically program human iPSCs into a chosen cell identity with unprecedented biological consistency at an industrial scale, and approximately 10 times faster than conventional methods. Our platform has the potential to unlock a new generation of medicines. Our io Cells research products provide scientists access to highly characterised, consistent, scalable human cells that enable … 334 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
2 | 121 |
|
Designing and delivering cell therapies to transform the lives of people with cancer. Adaptimmune is a fully integrated cell therapy company, designed and built from the ground up with four U.K.- and U.S.-based biotechnology hub locations. Our comprehensive capabilities and teams include preclinical research, clinical development, translational sciences, autologous and allogeneic manufacturing, and in-house commercial and corporate operations. For more information about Adaptimmune, please visit www.adaptimmune.com. If interested in joining our fast growing team, click on the careers tab of this page. Adaptimmune only accepts employment applications through our corporate website at Adaptimmune.com/Careers and through the ‘Easy Apply’ feature on … 58 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology |
2 | 121 |
|
Bioassociate provides biotech stock picking, expertise-based consulting, valuation and analysis services for investors and businesses operating in the life science arena. We operate exclusively on a dual-expertise model, assigning one life science and one finance expert to each project. Find out more at www.bioassociate.com Strategy-based consulting for the Life Sciences, Due Diligence, Business Analysis & Research for Investors, Biotech Consulting, Biotech stock picking & investment, and Industry & Technical Research Services Type: Startup Activities: consulting fintech |
0 | 0 |
|
BioPharmAnalyses is an information site that allows you to actively monitor and follow the strategic developments of companies in the biopharmaceutical sector. With BioPharmAnalyses: • You get a summary view of recent industry news • You are up to date with the latest key agreements and mergers and acquisitions • You follow the clinical and regulatory progress of products in development • You access the latest grants, fundraising and IPOs Its five databases include more than 13,000 interactive files on agreements, clinical trials, fundraising, mergers/acquisitions and the regulatory life of biopharmaceutical products in Europe and the United States. Each of … 55 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
16 | 2 |
|
Playing music to cells Kolibri revolutionises the way we grow and engineer cells at scale using acoustic waves. 🔍 Book a discovery call: https://calendly.com/tamsin_kolibrilab/discovery-call Showing 10x increase in cell density and 50x reduction in production costs, our patented bioreactors help our partners in drug development unlock patient access to gene therapies, with a proof of principle in AAV gene therapy. Being cell-agnostic and scalable, our process has significant potential across a range of high-value cell-based therapies - or in the cellular agriculture space more broadly. gene therapy, biomanufacturing, cellculture, acoustics, hardtech, and biotech 392 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology |
14 | 10 |
|
Ncardia believes that human stem cell (iPSCs) technologies will bring better therapies to patients faster. Ncardia is a drug discovery company and expert in human iPSC technology. We operate worldwide with facilities, offices and staff throughout Europe and North America. We work with biopharmaceutical companies in drug discovery worldwide, to leverage the power of stem cell technologies in the development of novel therapies of multiple modalities at any stage of development. Over the past 10 years, we have built the expertise and infrastructure required to differentiate, manufacture and characterize high-quality iPSC-derived cell and disease models. We can facilitate the process … 421 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
2 | 42 |
|
Fueled by Connections to Transform Rare DiseasesTM Agios is a commercial-stage biopharmaceutical company dedicated to redefining the future of rare disease treatment. Fueled by connections, we build trusted partnerships with rare disease communities, collaborating to develop and deliver innovative medicines with the potential to transform lives. Rooted in hematology, we combine deep biological expertise with real-world insights to advance a growing pipeline of medicines that reflect patients’ priorities. Our inclusive, collaborative culture sparks bold thinking and strengthens our connections – with each other and with the people we serve. Review our social media guidelines: https://www.agios.com/community-guidelines/ Biopharmaceuticals, Cellular Metabolism, and Rare … 319 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology |
9 | 676 |
|
Dedicated to driving more treatments to more patients more quickly by testing approved therapies for unsolved diseases Cures Within Reach leverages the speed, safety and cost-effectiveness of testing already approved therapies for new indications to improve patient quality and length of life, serving philanthropic and/or commercial uses – driving more treatments to more patients more quickly. Read about our ongoing trials at https://www.cureswithinreach.org/programs/current-repurposing-research-projects/. medical research, pharmaceutical, social entrepreneur, and philanthropy 64 similar entities Type: SMB Activities: biotech deeptech |
6 | 16 |
|
The Mechanisms-Based Medicine Company Bio-Modeling Systems is the world’s first Mechanisms-Based medicine company that changed the discovery paradigm to create novel medical meanings from unreliable heterogeneous sources of data to generate validated & directly exploitable first in class heuristic non-mathematical mechanistic CADITM Discovery models. We propose to R&D & Translational Medicine Executives, robust alternative decision-making to de-risk, save time, costs, and novel cost-effective diagnostics/therapies for their businesses. Created in 2004, profitable since 2006, thanks to our recurrent clients, we confirmed with our partners CADITM Discovery capability to generate outstanding value through: • Strong & long term strategic R&D collaborations (>100 … 132 similar entities Type: SMB Activities: healthtech deeptech biotech Technologies: A.I. |
11 | 6 |
|
We power your science Sartorius Polyplus is a leading upstream solutions provider for advanced biological and cell and gene therapy production from research to commercial scale. An innovator in nucleic acid delivery, the legacy portfolio features process-centric transfection reagents, kits, and support services. Custom plasmid vector design was integrated into the offer in 2022 as a first measure to expanding the products and services portfolio to help customers (or the industry) optimize process economics while meeting strict scientific and regulatory standards. We wanted to share that we will not be actively posting or engaging on this LinkedIn account. … 114 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology |
6 | 105 |
|
A biotech startup redefining our most basic understanding of the ageing process Based at the Babraham Research Campus in Cambridge, LinkGevity is a pioneering drug discovery company founded on ground-breaking research in longevity science. Our goal is to change the paradigm of ageing, paving the way for people to live healthier lives for longer. Contact us on info@linkgevity.com 130 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
9 | 12 |
|
Powering the Immune System to Transform Lives At Vir Biotechnology, Inc., we leverage the immense potential of the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. We focus on the therapeutic areas in which we believe we can most benefit patients. Our foundational efforts in chronic hepatitis delta are complemented by strategic programs in oncology. Every day, we work with the utmost urgency to deliver potentially transformative medicines for patients. Our pipeline is built on two technology platforms which enable us to rapidly identify, optimize and advance candidates from concepts to the … 89 similar entities Type: Startup Activities: deeptech biotech Technologies: SaaS |
10 | 453 |
|
#BeyondBoundaries At Sygnature Discovery, a global drug discovery CRO, we create exceptional scientific outcomes. For our customers, who bring life-changing medicines to patients; and for our people, who help make this possible. We’re 700+ scientists from over 50 countries, working as one across Europe and North America. With no competing internal programs, we offer total confidentiality and commitment. Over the past 20 years, we’ve earned a track record of real impact: 60+ advanced candidates, 200+ patents filed, 200+ active projects. Over 90% of our customers choose to stay with us – from biotechs racing to clinic to pharma companies that … 274 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology |
16 | 637 |
|
Better Access. Better Lives. Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars. Biopharmaceuticals, Research and Development, Biosimilars, Biotechnology, Pharmaceutical, Biogenerics, Health, Cell Line Development, Business Development, and Regulatory 411 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology |
1 | 1,181 |
|
Driving Bio-Industry Growth as Michigan's only state-wide life-sciences association. The Advocate for Michigan's bio-industry! MichBio is a non-profit association representing more than 600 bioscience companies, universities and academic institutions dedicated to advancing Michigan's bioscience industry. MichBio is the state's leading advocate for the bio-industry. MichBio fosters an environment that educates the public and policy makers, influences public policy and advances the economic interests of its member companies and the industry as a whole. Creating Value, Building Networks, Impacting Policy, and Growing Talent 48 similar entities Type: SMB Activities: biotech deeptech |
12 | 8 |
|
The fund against neuroblastoma childhood cancer The Villa Joep Foundation raises funds to accelerate research into neuroblastoma childhood cancer. 100% of all donations are spent on research. Between 25 and 30 children per year are diagnosed with neuroblastoma. Because the most severe form still only has a survival rate of 35%, Villa Joep wants more research to be done on neuroblastoma so that survival rates can increase. Villa Joep does this by connecting and working together. With families and fellow sufferers, hundreds of international researchers and approximately 45 volunteers. By encouraging and financing research, the day will come when no … 18 similar entities Type: SMB Activities: fintech |
2 | 17 |
|
Ventures at the crossroad of Health and Technology CRB is a Private Venture Capital Management firm specialized in Health Technologies. It was founded by a senior multi-disciplinary executive team. It has incorporated three previous Funds with focus on Biotech (Fund I), Medtech (Fund II), and Digital Health (Fund Nuubo). Currently incorporating the Fund III (CRB Digital Health III), a specialized Fund on Digital Health supported by a team with a large experience in startups, scaleups, corporates, and public health institutions. Based in Madrid and Barcelona, with access to the most innovative hubs in Europe. comunicacion@crossroadbiotech.com Lactose intolerance, Alzheimer, Wearable technologies, … 141 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. |
9 | 2 |
|
GRIDX is the leading early-stage venture capital fund for non-therapeutic biotech in Latin America GRIDX is the leading venture capital fund for biotech (non therapeutics) startups in Latin America. With a portfolio of over 90 startups across 8 countries and over 9 years of experience, we have been pioneers in connecting Latin American science with venture capital through our venture-building program. Each year, we run a discovery and transformation process for scientific and business talent, aiming to co-found startups that develop disruptive solutions based on laboratory-generated knowledge. We invest USD 250,000 in these startups and connect them with the world … Type: Startup Activities: deeptech Technologies: Decarbonization |
7 | 21 |
|
The highest-rated breast cancer org in the U.S. We fund research to find a cure in our lifetime. BCRF is the highest-rated breast cancer organization in the U.S. We provide critical funding for cancer research worldwide to fuel advances in tumor biology, genetics, prevention, treatment, metastasis and survivorship. Since our founding in 1993 by Evelyn H. Lauder, BCRF has raised more than half a billion dollars for lifesaving research. Through a unique and streamlined grants program, we seek out the brightest minds in science and medicine and give them the necessary resources to pursue their best ideas. As a result, … 53 similar entities Type: SMB Activities: biotech deeptech |
10 | 114 |
|
The global network for R&D collaboration Halo is a partnering platform that helps corporate R&D teams discover new technologies, build relationships with the researchers and startups behind them, and more efficiently scale external partnerships globally through the power of networks and AI. Since launching in January 2020, more than 7,000 universities from 135+ countries have joined the platform. In 2021, Halo was recognized as one of Fast Company's 2021 World Changing Ideas. On Halo, corporate R&D divisions post areas of interest for research collaborations (ie. Request-For-Proposals) and interested parties (scientists, startups, suppliers, innovators, etc.) submit a simple, standardized proposal form. … 22 similar entities Type: Startup Activities: biotech deeptech fintech Technologies: Synthetic Biology |
25 | 158 |
|
CRO specialized in pharmaceutical drugability for research Expertise in Human and Animal health solid form characterization and formulation development. We deliver both experimental support and consulting services to biotechnology and pharmaceutical companies, not-for-profit organizations and complementary CROs. We are member of the association AFSSI, 1st French research center in Life Sciences, as a founding member and member of the board of Directors. Since March 2019 Joel Vacus, Drugabilis CEO & CSO, is vice-President of AFSSI. https://www.afssi.fr/ Feel free to contact us in order to exchange about your preclinical drug development! contact@drugabilis.com Lead optimization, Formulation, and Physical form optimization 165 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology |
1 | 7 |
|
Helping patients getting self-ownership over their genomic data THE HUMAN GENOME FOUNDATION IS A REGISTERED CHARITY (ANBI) COMMITTED TO AFFECTING LASTING CHANGE ON A GLOBAL LEVEL. The Global Human Genome Foundation has been founded in 2017 with a single purpose: to create a world where vital and live saving information is within reach of people who need it most. The founder experienced that there is more information about genomics to save lives. Hence our mission is to make this information available for all people. By building a future where all people have access to their genomic data and lifesaving knowledge. … 25 similar entities Type: Startup Activities: healthtech Technologies: Cybersecurity |
0 | 3 |
|
BioCentury gives biopharma executives, investors and institutions the power to make business-critical decisions through independent, deep-dive analysis; high-quality data; and industry-leading business intelligence, and global events. When you subscribe to BioCentury, our team of Ph.D.s, analysts and industry experts become an extension of your team, helping you answer critical questions, decipher strategic trends, objectively evaluate product and business strategies, and assess competitive, financial, and policy risks. We also help you to build your network by connecting you the who’s who in the industry. Watch the latest episodes of The BioCentury Show on YouTube www.biocenturyyoutube.com Subscribe to the "BioCentury This Week" … 46 similar entities Type: SMB Activities: fintech Technologies: Data Analytics |
43 | 84 |
|
IOCB Tech is a technology transfer office and subsidiary company of IOCB Prague. IOCB Tech is at the forefront of technology transfer in the Czech Republic, specializing in pharmaceutical, chemical, and biotechnology research and development. As a subsidiary of IOCB Prague (Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences in Prague), we're dedicated to driving innovation and collaboration. Our mission? Bridging the gap between cutting-edge research and real-world applications. We're all about turning the remarkable results of Czech scientists' foundational work into practical solutions, be it in medicinal chemistry, material sciences, biology, or other domains of … 73 similar entities Type: Startup Activities: deeptech Technologies: New Materials |
5 | 23 |
|
Dedicated to the treatment of metabolic, fibrotic and inflammatory diseases Liminal BioSciences, through its wholly owned subsidary, Caledon Bioscience Inc., is a data-driven development-stage biopharmaceutical company focused on discovering and developing novel and distinctive small molecule therapeutics that modulate G protein-coupled receptor pathways (GPCRs). We are designing proprietary novel small molecule therapeutic candidates with the intent of developing best/first in class therapeutics for the treatment of metabolic, inflammatory and fibrotic diseases with significant unmet medical needs, using our drug discovery and medicinal chemistry expertise and deep understanding of GPCR biology. Our registered office is located in Belleville, Ontario and we … 171 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology |
1 | 19 |
|
Making the hope of early detection, a reality. Meet the team behind iBreastExam and cervAIcal! UE LifeSciences is a fast-growing, multi-national med-tech company bringing the promise of early detection of cancer to women globally. Our innovations have reached more than 250,000 women in 12 countries. We've grown revenue five-fold in the past three years with distribution in 10 countries and counting. And we've raised over $6 million in grants, international awards and equity capital! Our work is featured on platforms such as TED Talks and notable publications such as The New York Times, BBC World News, Forbes and others. Medical … 128 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology |
10 | 65 |
|
Speeding up the research revolution with you. DNAsimple, now part of Joined Bio, continues its mission to make participant engagement simple, secure, and rewarding. Through Joined Bio, we enable researchers to access qualified participants, biospecimens, and real-world data quickly and ethically, accelerating discovery and improving lives, all from the comfort of home. Together, we are building a more connected and transparent research ecosystem that bridges people and science. Request a quote today: https://joined.bio/quote-request/ genetics, genomics, biobanking, genetic research, saliva , DNA, DNA sample, microbiome, donor compensation, DNAsimple, healthcare research, and personalized medicine 98 similar entities Type: Startup Activities: biotech deeptech Technologies: Data Analytics |
3 | 6 |
|
Proprietary engagement platforms powering the life sciences with clinical trial participants and patient journey data. MedAnswers builds highly engaged disease communities through easy-to-use engagement platforms for both patients and professionals. We match consumers with a network of trusted experts who can answer their personal questions, provide access to life-affirming clinical trials and use machine learning to match users to research, products and solutions specific to their health needs. Life-sciences companies can receive high-value market data products including hard-to-get behavioral data, natural history data and real world evidence. Researchers can recruit more patients for their clinical trials in half the amount … 120 similar entities Type: Startup Activities: deeptech healthtech Technologies: A.I. A.I. - Machine Learning Data Analytics |
5 | 8 |
|
Promoting the future of biochemistry and molecular biology. Founded in 1911, the Biochemical Society exists to advance molecular bioscience, promoting its importance as an academic discipline, from grassroots level to government policy, and highlighting its role in positively effecting societal challenges. Offering an extensive programme of scientific meetings and training events, grants and awards, educational resources, policy work and public engagement, we provide support for researchers and scientists across all career stages. We also publish 7 journals through our wholly-owned publisher, Portland Press, disseminating world-leading research and reviews that cover the breadth of the molecular biosciences. 14 similar entities Type: SMB Activities: healthtech |
13 | 167 |
|
Connecting the scienctific community and patient care to advance HCT and cellular therapies. Join our community! 🌎 EBMT is a non-profit medical and scientific organisation established in 1974. We host a unique patient registry providing a pool of data to perform studies and assess new trends in the field of HCT, cellular and gene therapies. We aim to be the connection between patients, researchers and other stakeholders to anticipate the future of cellular and stem cell-based therapies. Our community of healthcare professionals is focused on innovation, research and the advancement of these fields to save and improve the lives of … 75 similar entities Type: SMB Activities: edtech Technologies: Synthetic Biology |
9 | 220 |
|
Transforming drug discovery and materials research Schrödinger’s industry-leading computational platform facilitates the research efforts of biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger also has wholly-owned and collaborative drug discovery programs in a broad range of therapeutic areas. Schrödinger is deeply committed to investing in the science and talent that drive its computational platform. Schrödinger was founded in 1990 and is engaged with customers and collaborators in more than 70 countries. We welcome you to visit our blog at www.extrapolations.com. Stay Alert: Avoid Recruitment Scams Across industries, cybercriminals are posing as company recruiters using fake job postings … 53 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology |
3 | 997 |
|
Innovations and thought leadership across clinical, medical, and commercial strategy. Clinical & Commercial on Scientist.com (formerly HealthEconomics.com) showcases the expertise, technologies, and innovations driving clinical development, medical affairs, HEOR, RWE, market access, and commercialization. As part of the Scientist.com Innovation Hub, we connect life science professionals with webinars, podcasts, articles, white papers, and thought leadership from Scientist.com's global network of providers. Our content highlights the organizations, capabilities, and emerging approaches helping biopharma teams generate evidence, communicate value, improve patient access, and bring therapies to market more effectively. Building on HealthEconomics.com's longstanding role as a trusted source of industry knowledge, Clinical … 47 similar entities Type: SMB Activities: biotech deeptech Technologies: IoT |
5 | 1 |
|
An independent news organization covering genetics, genomics, and molecular diagnostics. GenomeWeb is an independent online news organization based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and molecular diagnostics. GenomeWeb’s editorial mission is to cover the scientific and economic ecosystem spurred by the advent of high-throughput genome sequencing. We operate the largest online newsroom focused on advanced molecular research tools in order to provide our readers with exclusive news and in-depth analysis of this rapidly evolving market. GenomeWeb users … 52 similar entities Type: SMB Activities: deeptech biotech |
10 | 39 |
|
Alzforum, founded in 1996, is a free, dynamic, web-based scientific community dedicated to understanding Alzheimer's disease and related disorders. Our editorial priorities are as diverse as the needs of the research community. The website reports news on the latest scientific findings from basic research to clinical trials; maintains public databases of animal models, therapeutics, genetic risk factors, and biomarkers; and holds live discussion forums to promote debate, speed the dissemination of new ideas, and break down barriers across the numerous disciplines that can contribute to the global effort to cure Alzheimer's disease. The Alzforum team of professional science writers and … 39 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology |
0 | 14 |
|
Giving Life to Science PureTech Health is a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value. We do this through a proven, capital-efficient R&D model focused on opportunities with validated pharmacology and untapped potential to address significant patient needs. This strategy has produced dozens of therapeutic candidates, including three that have received U.S. FDA approval. By identifying, shaping, and de-risking these high-conviction assets, and scaling them through dedicated structures backed by external capital, we accelerate their path to patients while creating sustainable value for shareholders. For more information, visit www.puretechhealth.com or connect with us … 183 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology |
17 | 76 |
|
Helps you make a career in Life Science Industry India’s #1 Biotech Career Platform | Helping Millions Biotech & Life Science Students Upskill, Publish, Get Certified & Land Successful Jobs | BIO-IT | Bioinformatics | AI ML | CODING | CSIR NET | GATE | Career Mentorship Biotecnika Info Labs Pvt Ltd is a premier Bio-IT company specializing in Biotechnology and Information Technology. We provide cutting-edge training in Bioinformatics, AI, ML, Computational Biology, Cheminformatics, and Coding for Biologists, complemented by research-oriented project work to give students valuable hands-on experience. Recognized as the top brand for CSIR NET Life Sciences coaching, … 46 similar entities Type: SMB Activities: deeptech biotech Technologies: SaaS |
1 | 364 |
|
Since 1987, we've granted nearly $100M to cancer research. For over three decades, Swim Across America has been giving hope by granting nearly $100 million dollars from its charity swims to fund cancer research and clinical trials. Learn more at swimacrossamerica.org Cancer research, Cancer clinical trials, Cancer Investigation, Swimming, Fundraiser, and Non-Profit 40 similar entities Type: SMB Activities: biotech deeptech |
6 | 77 |
|
Cell Press publishes over 50 scientific journals across the life, physical, earth, and health sciences, both independently and in partnership with scientific societies. Our story began over 45 years ago with the journal Cell and a commitment to publishing exciting biology. Today, we are bringing our editorial excellence, commitment to innovation, unparalleled reach and visibility, and passion for advocacy to all areas of scientific exploration as we work to publish and share science that inspires. To learn more, visit www.cell.com/about. Publishing, Biomedical Journals, Life Science Journals, and Research Reviews 71 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology |
29 | 1 |
|
We started Forward for one reason, and one reason only. To get healthcare to the people who need it most. Forward is a startup redesigning the way we deliver healthcare using all the technologies healthcare has neglected: sensors, mobile, and AI. We were founded in January 2016 by former executives and engineering leaders from Google and Uber and led by serial-entrepreneur, Adrian Aoun. We are funded by some of the world's best investors and entrepreneurs including First Round Capital, Eric Schmidt (Google/Alphabet chairman), Marc Benioff (Salesforce founder), Joe Lonsdale (Palantir founder), Joshua Kushner (Oscar co-founder) and Garrett Camp (Uber co-founder). … 177 similar entities Type: SMB Activities: deeptech healthtech it services Technologies: A.I. |
5 | 444 |
|
Executive & Interim Search for Life Sciences PIR International provides innovative senior level recruitment solutions to small and multinational life science organisations. We are recruitment specialists who understand the vision, commercial imperatives and research needs of the world’s leading life science organisations. Based in London, UK, PIR serves clients across the international life science sector, spanning pharma, biotech, diagnostic and medical device companies. Using over 100 years of combined experience and a powerful industry network, we find the right senior talent to drive organisations forward. PIR International specialise in C-suite and senior management roles, whether on a permanent or interim … 83 similar entities Type: SMB Activities: deeptech biotech healthtech transporttech hrtech Technologies: Synthetic Biology |
4 | 20 |